Instead, miR‐103a‐5p showed a highly significant down‐regulation in 75% of SMA patients in comparison to healthy control subjects and to other diseases.
1
—
—
Instead, miR‐103a‐5p showed a highly significant down‐regulation in 75% of SMA patients in comparison to healthy control subjects and to other diseases.